Archaea methanogens are associated with cognitive performance through the shaping of gut microbiota, butyrate and histidine metabolism

• Published in: Gut microbes Vol. 17; no. 1; p. 2455506
• Main Authors: Fumagalli, Andrea, Castells-Nobau, Anna, Trivedi, Dakshat, Garre-Olmo, Josep, Puig, Josep, Ramos, Rafel, Ramió-Torrentà, Lluís, Pérez-Brocal, Vicente, Moya, Andrés, Swann, Jonathan, Martin-Garcia, Elena, Maldonado, Rafael, Fernández-Real, José Manuel, Mayneris-Perxachs, Jordi
• Format: Journal Article
• Language: English
• Published: United States Taylor & Francis 01.12.2025; Taylor & Francis Group
• Subjects: Aged; archaea; Archaea - classification; Archaea - genetics; Archaea - metabolism; Bacteria - classification; Bacteria - genetics; Bacteria - isolation & purification; Bacteria - metabolism; Butyrates - metabolism; cognition; Cognition - physiology; cognitive flexibility; Cohort Studies; executive function; Female; Gastrointestinal Microbiome - physiology; Histidine - metabolism; Humans; Male; Metagenomics; Microbiota; Middle Aged; Research Paper; Microbiota; cognition; cognitive flexibility; archaea; executive function
• DOI: 10.1080/19490976.2025.2455506
• ISSN: 1949-0976; 1949-0984

The relationship between bacteria, cognitive function and obesity is well established, yet the role of archaeal species remains underexplored. We used shotgun metagenomics and neuropsychological tests to identify microbial species associated with cognition in a discovery cohort (IRONMET,  = 125). Interestingly, methanogen archaeas exhibited the strongest positive associations with cognition, particularly ( ). Stratifying individuals by median-centered log ratios (CLR) of (low and high groups: LMs and HMs) revealed that HMs exhibited better cognition and distinct gut bacterial profiles (PERMANOVA  = 0.001), characterized by increased levels of Verrucomicrobia, Synergistetes and Lentisphaerae species and reduced levels of Bacteroidetes and Proteobacteria. Several of these species were linked to the cognitive test scores. These findings were replicated in a large-scale validation cohort (Aging Imageomics,  = 942). Functional analyses revealed an enrichment of energy, butyrate, and bile acid metabolism in HMs in both cohorts. Global plasma metabolomics by CIL LC-MS in IRONMET identified an enrichment of methylhistidine, phenylacetate, alpha-linolenic and linoleic acid, and secondary bile acid metabolism associated with increased levels of 3-methylhistidine, phenylacetylgluamine, adrenic acid, and isolithocholic acid in the HMs group. Phenylacetate and linoleic acid metabolism also emerged in the Aging Imageomics cohort performing untargeted HPLC-ESI-MS/MS metabolic profiling, while a targeted bile acid profiling identified again isolithocholic acid as one of the most significant bile acid increased in the HMs. 3-Methylhistidine levels were also associated with intense physical activity in a second validation cohort (IRONMET-CGM,  = 116). Finally, FMT from HMs donors improved cognitive flexibility, reduced weight, and altered SCFAs, histidine-, linoleic acid- and phenylalanine-related metabolites in the dorsal striatum of recipient mice. seems to interact with the bacterial ecosystem affecting butyrate, histidine, phenylalanine, and linoleic acid metabolism with a positive impact on cognition, constituting a promising therapeutic target to enhance cognitive performance, especially in subjects with obesity.